Daunomycin and hypermetabolism Patient Reports February 11, 2012



Daunomycin Side Effects Report #4633176-1
Daunomycin side effect was reported by a Consumer or non-health professional from on Apr 11, 2005. Male patient, weighting 180.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, agitation, apnoea, hypermetabolism, hypoxia, lung infiltration, mental status changes, metabolic disorder What is  metabolic disorder, pyrexia. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8, 15, AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, ELSPAR, METHOTREXATE. Patient recovered.

Daunomycin Side Effects Report #4652123-X
Daunomycin side effect was reported by a Consumer or non-health professional from on May 02, 2005. Male patient, weighting 180.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunomycin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, agitation, ammonia increased, apnoea, haemodialysis, hypermetabolism, hypoxia, mental status changes, pyrexia. Daunomycin dosage: 60 MG/M2 IVP ON DAYS 1, 8, 15, AND 22. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Daunomycin